tirzepatide does what Do? Mechanism, Uses & Results How Does Tirzepatide Support Weight

Evidence-based protocols

SGLT2 inhibitors, used in the treatment of type 2 DM, have an average half-life of 11-13 hours, so most articles suggested withholding the drug three days before any elective surgery but some articles suggested a longer withholding period based on other precipitating factors contributing to euglycemic DKA

Includes dosing protocols, timing strategies & results timeline.

David Joffe, BSPharm, CDE Tina Burge, PharmD Candidate Florida A&M University Kiet Ngo, Pharm D Candidate Mercer University Abnormalities in incretin

Diabetic ketoacidosis (DKA) is a medical emergency caused by insulin deficiency

Our study assessedthe efficacyand safety of the three primary tirzepatide (TZP) doses, 5 mg, 10 mg, and 15 mg using network meta-analysis to assess their relative impact on type 2 diabetes mellitus (T2DM) treatment.This study adhered to the ...